Compare Comcast Corporation (CMCSA) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Comcast Corporation vs Nuwellis Inc — how do they compare? Comcast Corporation trades at $25.63 (market cap $91.02B), while Nuwellis Inc trades at $1.49 (market cap $542.80K). The key difference: Comcast Corporation is far larger — about 167686.1× Nuwellis Inc's market cap, and Comcast Corporation pays a 5.15% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| CMCSA | NUWE | |
|---|---|---|
Market Cap | $91.02B | $542.80K |
Sector | Media | Technology |
52-Week High | $32.50 | $220.50 |
52-Week Low | $21.92 | $1.42 |
Enterprise Value | $173.74B | -$1.27M |
Dividend Yield | 5.15% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Comcast Corporation
Comcast is made up of three parts. The core cable business owns networks capable of providing television, internet access, and phone services to roughly 61 million U.S. homes and businesses, or nearly half of the country. About 56% of the homes in this territory subscribe to at least one Comcast service. Comcast acquired NBCUniversal from General Electric in 2011. NBCU owns several cable networks, including CNBC, MSNBC, and USA, the NBC broadcast network, several local NBC affiliates, Universal Studios, and several theme parks. Sky, acquired in 2018, is the dominant television provider in the U.K. and has invested heavily in exclusive and proprietary content to build this position. The firm is also the largest pay-television provider in Italy and has a presence in Germany and Austria.
Read more on CMCSA →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
